Notes / Company

Genomic Valley Biotech Ltd.

GVBL BSE 539206 ISIN INE574D01010 Agriculture

Fundamentals

Market cap: ₹10.19 cr
P/E: 339.71×
ROE: 9.13%
Debt / equity: 0.00
52-week range: 20.10 — 54.27

Research on Tijori Finance

Company snapshot

Genomic Valley Biotech Ltd.

Agriculture

₹9 cr

P/E 292.72×

Latest quarter · Mar 2026

Sales₹0 cr

Net profit−₹0 cr

Op. margin+10.5%

EPS−₹0.02

Strength & growth

Debt / equity0.00×

Current ratio5.73×

Sales CAGR+9.3%

The timeline — 1 note on Genomic Valley Biotech Ltd.

May 2026

29 May 26 · 7:24 PM IST Brief

Brief · Earnings · Micro cap

Genomic Valley Biotech revenue collapsed 68% to ₹26.75 lakhs in FY26

The biotech firm's top line shrank from ₹84.84 lakhs to ₹26.75 lakhs in one year. Net profit followed, falling to ₹3.03 lakhs.

Verify on exchange BSE filings for GVBL NSE filings for GVBL Tijori Finance company page